FDA — authorised 17 January 2013
- Application: NDA202278
- Marketing authorisation holder: TEVA BRANDED PHARM
- Local brand name: ZECUITY
- Indication: SYSTEM — IONTOPHORESIS
- Status: approved
🇺🇸 PROT-CL-NP101-015.01 in United States
FDA authorised PROT-CL-NP101-015.01 on 17 January 2013
Marketing authorisation
Frequently asked questions
Is PROT-CL-NP101-015.01 approved in United States?
Yes. FDA authorised it on 17 January 2013.
Who is the marketing authorisation holder for PROT-CL-NP101-015.01 in United States?
TEVA BRANDED PHARM holds the US marketing authorisation.